Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Fixed Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Fixed Capital/Sales(x) 0.520.400.320.300.29

What is the latest Fixed Capital/Sales ratio of MANKIND PHARMA ?

The latest Fixed Capital/Sales ratio of MANKIND PHARMA is 0.52 based on Mar2023 Consolidated results.
Year Fixed Capital/Sales
Mar20230.52
Mar20220.40
Mar20210.32
Mar20200.30
Mar20190.29

How is Fixed Capital/Sales of MANKIND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2023 0.52
30.00
Mar2022 0.4
25.00
Mar2021 0.32
6.67
Mar2020 0.3
3.45
Mar2019 0.29 -

Other Financial Ratios of MANKIND PHARMA


Compare Fixed Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -4% -8.3% 51.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 0.4% -0.4% 61.2% Stock Analytics
CIPLA ₹112,990.0 Cr -1.1% 1.7% 53.9% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 5.9% 11.3% 94.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr -0.1% 3.9% 20% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -2% -4.2% 29.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4%

-8.3%

51.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses